Ken Griffin Opko Health, Inc. Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Opko Health, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 127,000 shares of OPK stock, worth $162,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,000
Previous 228,200
44.35%
Holding current value
$162,560
Previous $301,000
34.88%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding OPK
# of Institutions
255Shares Held
195MCall Options Held
1.68MPut Options Held
126K-
Rubric Capital Management LP New York, NY47.8MShares$61.2 Million1.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.5MShares$48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY29.2MShares$37.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA11MShares$14.1 Million0.0% of portfolio
-
State Street Corp Boston, MA9MShares$11.5 Million0.0% of portfolio
About OPKO HEALTH, INC.
- Ticker OPK
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 771,960,000
- Market Cap $988M
- Description
- OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...